Akoya announced the launch of PhenoCode™ Signature Panels for high-throughput spatial biomarker discovery and validation on the PhenoImager® platforms, providing the flexibility to keep pace with the dynamic combination therapy landscape. Additionally, Akoya has brought new datasets of spatial imaging of complementary RNA and protein biomarkers on the PhenoCycler®-Fusion system, which reveal insights into tumor biology and immunotherapyresponse..https://www.gaiascience.com.sg/branddetails/akoya-biosciences